The New York Times: UB's Pelham weighs in on Canada's decision to suspend use of ADHD drug

An article in Saturday's issue of The New York Times looks at Canada's decision to suspend use of Aderall for treatment of ADHD and quotes William Pelham, UB Distinguished Professor of psychology, pediatrics and psychiatry, who says depending on the dosages, longer-acting versions of the drugs may expose children to more of the stimulants than they would get by taking two separate doses of shorter-acting drugs. Go to article.